WOMEN & INFANTS HOSPITAL OF RHODE ISLAND

Women & Infants Hospital of Rhode Island specializes in clinical research and operational support for reproductive health trials, with a focused expertise in conducting female-centric contraceptive clinical trials under federal oversight. Their core capabilities include designing and executing multi-site clinical protocols, managing patient recruitment and retention strategies, ensuring regulatory compliance with FDA and NIH standards, and delivering high-integrity data collection and monitoring for phase II and III trials. The organization brings deep institutional experience in gynecological research, ethical review coordination, and longitudinal patient follow-up within controlled trial environments, distinguishing itself through its commitment to women’s health equity and rigorous scientific methodology in reproductive science. The hospital has demonstrated sustained engagement with the Department of Health and Human Services, primarily supporting research initiatives under the National Institutes of Health related to contraceptive development and reproductive health outcomes. Their work for HHS centers on implementing large-scale, multi-center clinical networks that require precise operational coordination, standardized data governance, and adherence to Good Clinical Practice guidelines. Their primary industry focus is in research and development within the life sciences, specifically in non-biotechnological clinical trial execution for reproductive health interventions. This positions them as a specialized provider in clinical research services for female reproductive systems, distinct from broader biotech or pharmaceutical R&D firms. As a non-federal, nonprofit healthcare institution based in Providence, Rhode Island, the organization operates with a mission-driven structure focused on maternal and reproductive health. While no formal government certifications are listed, their institutional credibility stems from longstanding clinical research infrastructure, IRB governance, and participation in federally funded trial networks. Their geographic footprint is anchored in New England, with a national reach through participation in HHS-supported research consortia.